Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| vTv Therapeutics Inc.VTVT · Entity 6614 | Director | August 17, 2022 | June 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
vTv Therapeutics Inc.
Report date August 17, 2022 · Filed June 21, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director stock option (right to buy)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
Holding disclosure · report date 2022-08-17 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 0 F1: This Form 4 is being amended to correct the reported option award and holdings of the Reporting Person as of August 17, 2022. The option award was made in error as the Reporting Person has elected not to receive equity awards in connection with his service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being amended to correct the reported option award and holdings of the Reporting Person as of August 17, 2022. The option award was made in error as the Reporting Person has elected not to receive equity awards in connection with his service as a director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2022 Filed Aug 18, 2022 23:04 UTC | vTv Therapeutics Inc. VTVT · Entity 6614 | GrantDirector stock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0000950142-22-002566 · es220280057_4-isaacsohn.xml · derivative · entry 1 Isaacsohn Jonathan · CIK 0001943095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2032-08-12 F1 · derivative.exercise_date: Vests on August 9, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.